الملخص

An 8-year-old child with Stage 3A Coats' disease and severe submacular lipid exudation was initially treated with intravitreal injections of bevacizumab followed by triamcinolone. The exudative retinal detachment was then treated by scleral buckling, cryotherapy of persistent telangiectasia, and subretinal fluid drainage. The residual telangiectasia on the reattached retina was finally ablated by photocoagulation. The patient had a near-total resolution of submacular hard exudates without macular fibrosis. The peripheral telangiectasia and exudative detachment also regressed, with the sustained recovery of excellent visual acuity.

الكلمات المفتاحية

بيانات النشر

المعرّف الرقمي
10.4103/ojo.ojo_249_21
المجلة
المجلة العُمانية لطب العيون, 15(3), 382-384
الناشر
منشورات ميدنو
وصول مفتوح
وصول مفتوح ذهبي

اقتبس هذه المقالة

APA 7

Shukla, D. (2022). Advanced Coats' disease: Treating the effect before the cause. Oman Journal of Ophthalmology, 15(3), 382-384. https://doi.org/10.4103/ojo.ojo_249_21

MLA 9

Shukla, Dhananjay. "Advanced Coats' disease: Treating the effect before the cause." Oman Journal of Ophthalmology, vol. 15, no. 3, 2022, pp. 382-384. https://doi.org/10.4103/ojo.ojo_249_21.

شيكاغو (المؤلف–التاريخ)

Shukla, Dhananjay. 2022. "Advanced Coats' disease: Treating the effect before the cause." Oman Journal of Ophthalmology 15 (3): 382-384. https://doi.org/10.4103/ojo.ojo_249_21.

هارفارد

Shukla, D. (2022) 'Advanced Coats' disease: Treating the effect before the cause', Oman Journal of Ophthalmology, 15(3), pp. 382-384. doi:10.4103/ojo.ojo_249_21.

فانكوفر

Shukla D. Advanced Coats' disease: Treating the effect before the cause. Oman Journal of Ophthalmology. 2022;15(3):382-384. doi:10.4103/ojo.ojo_249_21

IEEE

D. Shukla, "Advanced Coats' disease: Treating the effect before the cause," Oman Journal of Ophthalmology, vol. 15, no. 3, pp. 382-384, 2022, doi: 10.4103/ojo.ojo_249_21.